BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28849144)

  • 1. Amplification by (‑)‑epigallocatechin gallate of prostaglandin F2α‑stimulated synthesis of osteoprotegerin in osteoblasts.
    Sakai G; Otsuka T; Fujita K; Kainuma S; Kuroyanagi G; Kawabata T; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
    Mol Med Rep; 2017 Nov; 16(5):6376-6381. PubMed ID: 28849144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (-)-Epigallocatechin gallate synergistically potentiates prostaglandin E
    Kuroyanagi G; Tokuda H; Yamamoto N; Kainuma S; Fujita K; Ohguchi R; Kawabata T; Sakai G; Matsushima-Nishiwaki R; Harada A; Kozawa O; Otsuka T
    Prostaglandins Other Lipid Mediat; 2017 Jan; 128-129():27-33. PubMed ID: 28163121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (--)-epigallocatechin gallate enhances prostaglandin F2alpha-induced VEGF synthesis via upregulating SAPK/JNK activation in osteoblasts.
    Tokuda H; Takai S; Matsushima-Nishiwaki R; Akamatsu S; Hanai Y; Hosoi T; Harada A; Ohta T; Kozawa O
    J Cell Biochem; 2007 Apr; 100(5):1146-53. PubMed ID: 17031857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (-)-Epigallocatechin gallate but not chlorogenic acid suppresses EGF-stimulated migration of osteoblasts via attenuation of p38 MAPK activity.
    Kawabata T; Otsuka T; Fujita K; Sakai G; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
    Int J Mol Med; 2018 Dec; 42(6):3149-3156. PubMed ID: 30272256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (-)-Epigallocatechin gallate amplifies interleukin-1-stimulated interleukin-6 synthesis in osteoblast-like MC3T3-E1 cells.
    Kuroyanagi G; Otsuka T; Kondo A; Matsushima-Nishiwaki R; Mizutani J; Kozawa O; Tokuda H
    Biochimie; 2013 Oct; 95(10):1933-8. PubMed ID: 23851196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (-)-Epigallocatechin gallate reduces platelet-derived growth factor-BB-stimulated interleukin-6 synthesis in osteoblasts: suppression of SAPK/JNK.
    Takai S; Matsushima-Nishiwaki R; Adachi S; Natsume H; Minamitani C; Mizutani J; Otsuka T; Tokuda H; Kozawa O
    Mediators Inflamm; 2008; 2008():291808. PubMed ID: 19148296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation by AMP-activated protein kinase of PGE2-induced osteoprotegerin synthesis in osteoblasts.
    Kainuma S; Otsuka T; Kuroyanagi G; Yamamoto N; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
    Mol Med Rep; 2016 Apr; 13(4):3363-9. PubMed ID: 26935864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of prostaglandin E1‑induced osteoprotegerin synthesis in osteoblasts by normoxic HIF inducers.
    Kuroyanagi G; Tokuda H; Yamamoto N; Kainuma S; Fujita K; Ohguchi R; Matsushima-Nishiwaki R; Kozawa O; Otsuka T
    Mol Med Rep; 2017 Apr; 15(4):1847-1852. PubMed ID: 28259984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (-)-Epigallocatechin gallate suppresses endothelin-1-induced interleukin-6 synthesis in osteoblasts: inhibition of p44/p42 MAP kinase activation.
    Tokuda H; Takai S; Hanai Y; Matsushima-Nishiwaki R; Hosoi T; Harada A; Ohta T; Kozawa O
    FEBS Lett; 2007 Apr; 581(7):1311-6. PubMed ID: 17350626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol suppresses prostaglandin F(2α)-induced osteoprotegerin synthesis in osteoblasts: inhibition of the MAP kinase signaling.
    Kuroyanagi G; Tokuda H; Matsushima-Nishiwaki R; Kondo A; Mizutani J; Kozawa O; Otsuka T
    Arch Biochem Biophys; 2014 Jan; 542():39-45. PubMed ID: 24333336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation by resveratrol of prostaglandin E2-stimulated osteoprotegerin synthesis in osteoblasts.
    Yamamoto N; Tokuda H; Kuroyanagi G; Mizutani J; Matsushima-Nishiwaki R; Kondo A; Kozawa O; Otsuka T
    Int J Mol Med; 2014 Nov; 34(5):1439-45. PubMed ID: 25234201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (-)-epigallocatechin gallate inhibits prostaglandin D2-stimulated HSP27 induction via suppression of the p44/p42 MAP kinase pathway in osteoblasts.
    Yamauchi J; Takai S; Matsushima-Nishiwaki R; Hanai Y; Doi T; Kato H; Ogura S; Kato K; Tokuda H; Kozawa O
    Prostaglandins Leukot Essent Fatty Acids; 2007; 77(3-4):173-9. PubMed ID: 17949962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetaminophen reduces osteoprotegerin synthesis stimulated by PGE
    Kim W; Tokuda H; Tanabe K; Yamaguchi S; Hioki T; Tachi J; Matsushima-Nishiwaki R; Kozawa O; Iida H
    Biomed Res; 2021; 42(2):77-84. PubMed ID: 33840687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification by (-)-epigallocatechin gallate and chlorogenic acid of TNF-α-stimulated interleukin-6 synthesis in osteoblasts.
    Yamamoto N; Tokuda H; Kuroyanagi G; Kainuma S; Ohguchi R; Fujita K; Matsushima-Nishiwaki R; Kozawa O; Otsuka T
    Int J Mol Med; 2015 Dec; 36(6):1707-12. PubMed ID: 26496857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol reduces prostaglandin E1-stimulated osteoprotegerin synthesis in osteoblasts: suppression of stress-activated protein kinase/c-Jun N-terminal kinase.
    Yamamoto N; Otsuka T; Kuroyanagi G; Kondo A; Kainuma S; Nakakami A; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
    Prostaglandins Other Lipid Mediat; 2015; 116-117():57-63. PubMed ID: 25677506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mimosine suppresses the PGF2α-induced synthesis of osteoprotegerin but not interleukin-6 in osteoblasts.
    Kuroyanagi G; Otsuka T; Yamamoto N; Kainuma S; Ohguchi R; Fujita K; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
    Int J Mol Med; 2016 Feb; 37(2):533-41. PubMed ID: 26744072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncostatin M stimulates prostaglandin D
    Kuroyanagi G; Hioki T; Tachi J; Matsushima-Nishiwaki R; Iida H; Kozawa O; Tokuda H
    Prostaglandins Leukot Essent Fatty Acids; 2023 May; 192():102575. PubMed ID: 37094446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression by resveratrol of prostaglandin D2-stimulated osteoprotegerin synthesis in osteoblasts.
    Kuroyanagi G; Mizutani J; Kondo A; Yamamoto N; Matsushima-Nishiwaki R; Otsuka T; Kozawa O; Tokuda H
    Prostaglandins Leukot Essent Fatty Acids; 2014 Sep; 91(3):73-80. PubMed ID: 24813642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation by resveratrol of basic fibroblast growth factor-stimulated osteoprotegerin synthesis through suppression of Akt in osteoblasts.
    Kuroyanagi G; Otsuka T; Yamamoto N; Matsushima-Nishiwaki R; Nakakami A; Mizutani J; Kozawa O; Tokuda H
    Int J Mol Sci; 2014 Oct; 15(10):17886-900. PubMed ID: 25290095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PGD2 stimulates osteoprotegerin synthesis via AMP-activated protein kinase in osteoblasts: Regulation of ERK and SAPK/JNK.
    Kainuma S; Tokuda H; Kuroyanagi G; Yamamoto N; Ohguchi R; Fujita K; Matsushima-Nishiwaki R; Kozawa O; Otsuka T
    Prostaglandins Leukot Essent Fatty Acids; 2015 Oct; 101():23-9. PubMed ID: 26365271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.